Sign in

CIK 0001745648

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

Apnimed, Inc.

Sign in to watch
Ticker
APMD
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
821910611
Phone
+1 617-500-8880
Business address
39 JOHN F. KENNEDY STREET, 4TH FLR., CAMBRIDGE, MA, 02138
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2036-08-03 Kelly Michael B Chief Financial Officer Returned to the company · Stock Option (Right to Buy) −31,434 0
2036-08-03 Kelly Michael B Chief Financial Officer Grant or award · Stock Option (Right to Buy) +31,434 31,434
2036-07-30 Kelly Michael B Chief Financial Officer Grant or award · Stock Option (Right to Buy) +31,434 31,434
2026-08-03 Kelly Michael B Chief Financial Officer Returned to the company · Stock Option (Right to Buy) −333,580 0
2026-08-03 Kelly Michael B Chief Financial Officer Grant or award · Stock Option (Right to Buy) +333,580 333,580

Page 1 of 1 · 5 trades